Metraipolis › archive › dc_ec982e087402

Co-targeting CDK2 and CDK9 inhibits MYC oncogenic programs and has anti-tumor effects in CIC-rearranged sarcoma — Europe PMC PMID:42972022

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42972022
DOI
10.1038/s43856-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-11-07T12:42:27.169Z
SHA-256 of the archived text
c83489d6f7eff42f886e3f3f0c801e1c9fe99e9a85973803ce1505f00fe68edc
Stable URL of this page
https://metraipolis.com/documento/dc_ec982e087402

How to cite

Co-targeting CDK2 and CDK9 inhibits MYC oncogenic programs and has anti-tumor effects in CIC-rearranged sarcoma — Europe PMC PMID:42972022 — Europe PMC (en), https://europepmc.org/article/MED/42972022 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ec982e087402 (Metraipolis archive dc_ec982e087402, sha256 c83489d6f7eff42f886e3f3f0c801e1c9fe99e9a85973803ce1505f00fe68edc)
BibTeX
@misc{dcec982e087402,
  title = {Co-targeting CDK2 and CDK9 inhibits MYC oncogenic programs and has anti-tumor effects in CIC-rearranged sarcoma — Europe PMC PMID:42972022},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42972022},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ec982e087402; sha256 c83489d6f7eff42f886e3f3f0c801e1c9fe99e9a85973803ce1505f00fe68edc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42972022. Agents can read the archived copy with the MCP tool read_document.